300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis

300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis

Bibliographic Details
Main Authors: Thomas Wagner, Timothy Vreeland, Guy Clifton, George Peoples, Diane Hale, Mark Faries, Montaser Shaheen, Lexy Adams, Robert Chick, Patrick McCarthy, Anne O’Shea, Phil Kemp Bohan, Annelies Hickeron, John Myers, Jessica Cindass, John Hyngstrom, Adam Berger, James Jakub, Jeffrey Sussman
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items